| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
INSULIN-GLUCAGON-GI PEPTIDES-DIABETES MELLITUS |
University of Melbourne (S.K., S.Z., A.W.T., M.E.D., J.P., S.A.), Department of Medicine, Royal Melbourne Hospital, and Walter and Eliza Hall Institute (R.D., T.W.K.), Parkville, Victoria 3050, Australia
Address all correspondence and requests for reprints to: Sofianos Andrikopoulos, Ph.D., University of Melbourne, Department of Medicine, Royal Melbourne Hospital, Parkville, Victoria 3050, Australia. E-mail: . sof{at}unimelb.edu.au
Type 2 diabetes is characterized by a susceptibility to ß-cell failure. However, subjects at risk of developing type 2 diabetes, such as those with obesity or a family history of diabetes, have been shown to display hyperinsulinemia. Although this hyperinsulinemia may be an adaptive response to insulin resistance, the possibility that insulin hypersecretion may be a primary defect has not been thoroughly investigated. The DBA/2 mouse is a model of pancreatic islet susceptibility. Unlike the resistant C57BL/6 mouse strain, the DBA/2 mouse islet fails when stressed with insulin resistance or when exposed to chronic high glucose concentrations. The aim of this study was to compare insulin secretory function in the DBA/2 and C57BL/6 strains in the absence of insulin resistance or high glucose. Insulin secretion was assessed in vivo using the iv glucose tolerance test and in vitro using isolated islets in static incubations. It was shown that DBA/2 mice hypersecreted insulin in vivo, compared with C57BL/6 mice, at 1 d and at 4 and 10 wk of age. This hypersecretion was not attributable to insulin resistance (as assessed by the insulin tolerance test) or increased parasympathetic nervous system outflow. Insulin hypersecretion was also demonstrated in vitro. This was associated with higher glycolysis and glucose oxidation, and elevated activity (but not protein levels) of islet glucokinase and hexokinase. Furthermore, GLUT2 protein levels were higher, which may explain an increase in glucokinase activity in DBA/2 mouse islets. In summary, the DBA/2 mouse, a model of islet failure, has increased glucose-mediated insulin secretion from a very early age, which is associated with an increase in glucose utilization. Further studies will determine whether there is a link between insulin hypersecretion and subsequent ß-cell failure.
This article has been cited by other articles:
 |
|
 |
|
  M. Kebede, J. Favaloro, J. E. Gunton, D. R. Laybutt, M. Shaw, N. Wong, B. C. Fam, K. Aston-Mourney, C. Rantzau, A. Zulli, et al. Fructose-1,6-Bisphosphatase Overexpression in Pancreatic {beta}-Cells Results in Reduced Insulin Secretion: A New Mechanism for Fat-Induced Impairment of {beta}-Cell Function Diabetes, July 1, 2008; 57(7): 1887 - 1895. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. D. Berglund, C. Y. Li, G. Poffenberger, J. E. Ayala, P. T. Fueger, S. E. Willis, M. M. Jewell, A. C. Powers, and D. H. Wasserman Glucose Metabolism In Vivo in Four Commonly Used Inbred Mouse Strains Diabetes, July 1, 2008; 57(7): 1790 - 1799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Siebel, A. Mibus, M. J. De Blasio, K. T. Westcott, M. J. Morris, L. Prior, J. A. Owens, and M. E. Wlodek Improved Lactational Nutrition and Postnatal Growth Ameliorates Impairment of Glucose Tolerance by Uteroplacental Insufficiency in Male Rat Offspring Endocrinology, June 1, 2008; 149(6): 3067 - 3076. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Clee and A. D. Attie The Genetic Landscape of Type 2 Diabetes in Mice Endocr. Rev., February 1, 2007; 28(1): 48 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Freeman and R.D. Cox Type-2 diabetes: a cocktail of genetic discovery Hum. Mol. Genet., October 15, 2006; 15(suppl_2): R202 - R209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. C. Freeman, A. Hugill, N. T. Dear, F. M. Ashcroft, and R. D. Cox Deletion of Nicotinamide Nucleotide Transhydrogenase: A New Quantitive Trait Locus Accounting for Glucose Intolerance in C57BL/6J Mice. Diabetes, July 1, 2006; 55(7): 2153 - 2156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Lamont, S. Visinoni, B. C. Fam, M. Kebede, B. Weinrich, S. Papapostolou, H. Massinet, J. Proietto, J. Favaloro, and S. Andrikopoulos Expression of Human Fructose-1,6-Bisphosphatase in the Liver of Transgenic Mice Results in Increased Glycerol Gluconeogenesis Endocrinology, June 1, 2006; 147(6): 2764 - 2772. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Y. Huang, K. M. Boini, B. Friedrich, M. Metzger, L. Just, H. Osswald, P. Wulff, D. Kuhl, V. Vallon, and F. Lang Blunted hypertensive effect of combined fructose and high-salt diet in gene-targeted mice lacking functional serum- and glucocorticoid-inducible kinase SGK1 Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R935 - R944. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Andrikopoulos, C. M Massa, K. Aston-Mourney, A. Funkat, B. C Fam, R. L Hull, S. E Kahn, and J. Proietto Differential effect of inbred mouse strain (C57BL/6, DBA/2, 129T2) on insulin secretory function in response to a high fat diet J. Endocrinol., October 1, 2005; 187(1): 45 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Hull, M. R. Watts, K. Kodama, Z.-p. Shen, K. M. Utzschneider, D. B. Carr, J. Vidal, and S. E. Kahn Genetic background determines the extent of islet amyloid formation in human islet amyloid polypeptide transgenic mice Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E703 - E709. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Jamieson, M. M. W. Chong, G. R. Steinberg, V. Jovanovska, B. C. Fam, D. V. R. Bullen, Y. Chen, B. E. Kemp, J. Proietto, T. W. H. Kay, et al. Socs1 Deficiency Enhances Hepatic Insulin Signaling J. Biol. Chem., September 9, 2005; 280(36): 31516 - 31521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kooptiwut, M. Kebede, S. Zraika, S. Visinoni, K. Aston-Mourney, J. Favaloro, C. Tikellis, M. C Thomas, J. M Forbes, M. E Cooper, et al. High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction J. Mol. Endocrinol., August 1, 2005; 35(1): 39 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Rabaglia, M. P. Gray-Keller, B. L. Frey, M. R. Shortreed, L. M. Smith, and A. D. Attie {alpha}-Ketoisocaproate-induced hypersecretion of insulin by islets from diabetes-susceptible mice Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E218 - E224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Remedi, Joseph. C. Koster, K. Markova, S. Seino, T. Miki, B. L. Patton, M. L. McDaniel, and C. G. Nichols Diet-Induced Glucose Intolerance in Mice With Decreased {beta}-Cell ATP-Sensitive K+ Channels Diabetes, December 1, 2004; 53(12): 3159 - 3167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Funkat, C. M. Massa, V. Jovanovska, J. Proietto, and S. Andrikopoulos Metabolic Adaptations of Three Inbred Strains of Mice (C57BL/6, DBA/2, and 129T2) in Response to a High-Fat Diet J. Nutr., December 1, 2004; 134(12): 3264 - 3269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Tikellis, P. J. Wookey, R. Candido, S. Andrikopoulos, M. C. Thomas, and M. E. Cooper Improved Islet Morphology after Blockade of the Renin- Angiotensin System in the ZDF Rat Diabetes, April 1, 2004; 53(4): 989 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wu, W. Nicholson, S. M. Knobel, R. J. Steffner, J. M. May, D. W. Piston, and A. C. Powers Oxidative Stress Is a Mediator of Glucose Toxicity in Insulin-secreting Pancreatic Islet Cell Lines J. Biol. Chem., March 26, 2004; 279(13): 12126 - 12134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Biden, D. Robinson, D. Cordery, W. E. Hughes, and A. K. Busch Chronic Effects of Fatty Acids on Pancreatic {beta}-Cell Function: New Insights From Functional Genomics Diabetes, February 1, 2004; 53(90001): S159 - 165. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
